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ABSTRACT Soluble aggregates critically inﬂuence the chemical and biological aspects of amyloid protein aggregation, but
their population is difﬁcult to measure, especially in vivo. We take an optical ﬁber-based ﬂuorescence correlation spectroscopy
(FCS) approach to characterize a solution of aggregating amyloid-b molecules. We ﬁnd that this technique can easily resolve
aggregate particles of size 100 nm or greater in vitro, and the size distribution of these particles agrees well with that obtained
by conventional FCS techniques. We propose ﬁber FCS as a tool for studying aggregation in vivo.
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Recent studies suggest that the soluble aggregates of
amyloid-b peptide (Ab), rather than the amyloid deposits,
are the main pathogenic species in Alzheimer’s disease (AD)
(1–4). Similar species are also thought to be responsible for
many other aggregation-related diseases, such as Huntington’s
and Parkinson’s (2,5). Hence, many of the current clinical
strategies target these aggregates to prevent neuronal loss in
AD (6,7). Unfortunately, presymptomatic diagnosis of the
disease has achieved limited success (8). An effective stra-
tegy for diagnosis would be to detect the soluble aggregates,
which appear early and are potently toxic, in vivo. Moni-
toring the effectiveness of a candidate drug or a treatment
routine, say in a model animal, also requires monitoring of
these aggregates inside the brain over time.
In vitro, such aggregates can be detected using ﬂuores-
cence correlation spectroscopy (FCS) (9–11). FCS measure-
ments have helped uncover chemical agents that can lower
the population of these aggregates (11). Unfortunately, FCS
uses bulky optics, and at present it is not possible to use it
inside the brain. Here we explore the possibility of measur-
ing protein aggregation in a minimally invasive manner,
extending a recently demonstrated scheme that uses a single
mode ﬁber for obtaining FCS data from ﬂuorescent beads
(12). Comparatively lower sensitivity, higher background
ﬂuorescence, and higher photobleaching make this technique
inappropriate for detecting single ﬂuorescent molecules.
However, an aggregated protein particle, where a fraction of
the monomers is labeled with a ﬂuorophore, can present a
target much brighter than a single molecule, and may
possibly be amenable to the ﬁber technique. Here we monitor
an aggregating Ab solution in vitro with ﬁber-based FCS,
and compare the results with conventional FCS.
We ﬁrst calibrate the ﬁber FCS instrument with a solution
of ﬂuorescent beads of 13 nm radius. The ﬁber optic ar-
rangement is similar to that reported earlier (12). In this
setup, a single mode optical ﬁber (mode ﬁeld radius ¼ 1.7
mm) is used both for delivering the excitation light (543 nm)
and also for collecting the ﬂuorescence from the sample. This
setup is automatically confocal and can be used for FCS mea-
surements (12,13). We ﬁt the FCS data using the MEMFCS
routine (14), which analyzes the data in terms of a quasi-
continuous distribution of diffusion constants. Such analysis
is required for characterizing highly heterogeneous aggregat-
ing protein solutions (10,11). The size distribution obtained
from the bead solution using the ﬁber FCS setup is shown in
Fig. 1 (solid line). The single-peaked distribution is centered
around 30 ms. The size distribution obtained from the same
specimen using a conventional FCS instrument (15) of the
same specimen is shown as a dotted line in Fig. 1. We see
that the two size distributions are similar, except that the ﬁber
FCS curve is peaked at a time point that is 21 times higher
than that of the conventional FCS. This is due to the larger
probe volume of the ﬁber FCS instrument, and this provides a
size calibration for any unknown particle measured with this
technique.
We note that the probe volume can be theoretically cal-
culated from the geometry of the ﬁber and that of the optical
system, and agrees well with the experimentally observed
probe volume (12).
We then examine our ability to characterize the aggregation
state of an Ab solution by examining it in vitro, ﬁrst with ﬁber
FCS and then with conventional FCS. We prepare a 10-mM
Ab solution mixed with 100 nM rhodamine-labeled Ab
(RAb)(both purchased from rPeptide, Athens, GA) at pH 7.4
in HEPES buffer and incubate it for 6 h at room temperature.
Fig. 2 A shows the autocorrelation data (solid squares)
obtained from a ﬁber FCS measurement of this sample. The
data are ﬁt (solid line) with MEMFCS. The size distribution
obtained from this data is shown in Fig. 2 C (solid line). The
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same solution then is examined by conventional FCS. The
autocorrelation data and the ﬁt are shown in Fig. 2 B. The
error bars in the autocorrelation traces in all the ﬁgures are
calculated from 10 identical measurements for 3 min each.
The size distribution is plotted (as a dotted line) in Fig. 2 C.
The abscissa denotes the hydrodynamic size in nanometers.
This axis has been calibrated using the ratio of the size and
the diffusion time of the beads obtained from Fig. 1. The
ﬁber FCS data show the existence of a clear peak centered
around 200 nm, and extending from;130 to;270 nm. The
conventional FCS data on the other hand show a similar peak
at 210 nm, but in addition, they also show a peak at 2.1 nm.
The heights of the largest peaks are normalized to unity. The
similarity of the second peak observed in conventional and
that observed with ﬁber FCS establishes that the larger ag-
gregates can be effectively seen with ﬁber FCS. On the other
hand, it is clear that the peak at the smaller size range, which
contains themonomer and the small oligomers (the calculated
value of the hydrodynamic radius for themonomer is 1.7 nm),
is resolved only by conventional FCS.
We note here that due to the relatively long residence time
of the particles in the ﬁber FCS confocal volume, photo-
bleaching may be a concern. We estimate the probability of
bleaching from the molar extinction coefﬁcient for rhoda-
mine-B in water at 543 nm (;50,000 l/mol cm), and the
average intensity of the excitation light in the FCS obser-
vation volume (;3 3 1025 photons/m2). The number of
photons absorbed by a rhodamine label during the residence
time of an aggregate (;0.5 s) is ,1.2 3 105. The average
number of photons absorbed by a bioconjugated rhodamine-
6G molecule before photobleaching is ;3 3 105 (16). We
thus expect a large fraction of the oligomers to remain un-
bleached. Because the oligomers are multiply labeled, photo-
bleaching is unlikely to have a major effect on the FCS data.
We also examine a control Ab solution that has been aged
for 2 weeks, and that does not have appreciable amounts of
the soluble aggregates left in it. The ﬁber FCS instrument
does not show any appreciable correlation from this spec-
imen (Fig. 3 A), whereas the conventional FCS experiment
shows a short time correlation extending to;2 ms (Fig. 3 B).
The analysis of the conventional FCS data (Fig. 3 C, dotted
line) shows that the specimen only contains monomers and
small oligomers, and no appreciable amount of higher order
aggregates. This establishes the reliability of the ﬁber FCS
technique to faithfully report the presence or absence of the
large soluble aggregates in an aggregating amyloid-b solution.
The ability to resolve particles directly depends on the
signal/noise of the instruments. The results show that
FIGURE 1 Calibration of the ﬁber FCS instrument. The size
distributions obtained using ﬁber FCS (solid line) and conven-
tional FCS (dotted line) from ﬂuorescent beads of radius 13 nm.
FIGURE 2 Measurement from aggregating Ab solution. Auto-
correlation data (solid squares) with ﬁt (solid line) obtained from
10 mM Ab 1 100 nM RAb after 6 h of preparation of the solution
using (A) ﬁber FCS and (B) conventional FCS instrument. (C) Size
distributions obtained using ﬁber FCS (solid line) and conven-
tional FCS (dotted line). The size axis has been calibrated using
the data from Fig. 1.
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particles in the size range of 1.7–5.0 nm, which are most
likely labeled with a single ﬂuorescent label, do not have
adequate brightness to be observed by the ﬁber FCS tech-
nique. However, many reports have shown that the larger
soluble aggregates, or protoﬁbrils, are potently toxic to the
neuronal cells (1). These species are detected well by the
ﬁber FCS technique. Optical ﬁbers of diameters larger than
what has been used here have been introduced into living
rodents and their brains have been optically monitored over
long periods (17). If such ﬁbers are used for FCS, with some
amount of ﬂuorescently labeled amyloid-b introduced into
the cerebrospinal ﬂuid, it should be possible to monitor the
population of large soluble aggregates in vivo, e.g., in the
brain of an Alzheimer model mouse (18). This study thus
highlights a possible route toward quantitative monitoring of
the aggregation of physiological molecules in vivo.
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FIGURE 3 Measurement from an equilibrium Ab solution.
Autocorrelation data (solid squares) with ﬁt (solid line) obtained
from 10 mM Ab1 100 nM RAb after 2 weeks of preparation of the
solution using (A) ﬁber FCS and (B) conventional FCS instru-
ment. (C) Size distribution from conventional FCS (dotted line).
The size axis has been calibrated using the data from Fig. 1.
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